Athira Pharma, Inc. (ATHA) Stock

No profile data available.

About Athira Pharma, Inc. (ATHA)

Athira Pharma, Inc. (ATHA) is a healthcare company in the brain and nerve treatment drugs industry.

In Q2 2026 (the quarter ended June 30, 2026) revenue was $0.

Figures from company filings and market data; latest fiscal year ended December 31, 2024.

Sector: Healthcare
Industry: Brain and Nerve Treatment Drugs
Founded: 2011

Frequently asked questions

What companies are similar to Athira Pharma?

Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include SK Biopharmaceuticals Co., Ltd. (326030.KS), Whan In Pharm Co.,Ltd. (016580.KS), Oncolys BioPharma Inc. (4588.T), Marksans Pharma Limited (MARKSANS.NS).

Similar companies

SK Biopharmaceuticals (326030.KS)Whan In Pharm (016580.KS)Oncolys BioPharma (4588.T)Marksans Pharma (MARKSANS.NS)SanBio (4592.T)argenx (ARGX)

Industry and sector

Research and Development in Biotechnology (except Nanobiotechnology) industry Professional, Scientific, and Technical Services sector Healthcare sector data Stock screener Search all stocks

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099